<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35084661</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-6903</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurochemical research</Title>
          <ISOAbbreviation>Neurochem Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Down-Regulated microRNA-192-5p Protects Against Hypoxic-Ischemic Brain Damage via Regulation of YAP1-Mediated Hippo Signaling Pathway.</ArticleTitle>
        <Pagination>
          <StartPage>1243</StartPage>
          <EndPage>1254</EndPage>
          <MedlinePgn>1243-1254</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-021-03518-4</ELocationID>
        <Abstract>
          <AbstractText>Hypoxic-ischemic brain damage (HIBD) is a familiar neurological disorder. Emerging reports manifest that microRNAs (miRs) are related to the progression of HIBD. The goal of this study is to explore the mechanism of miR-192-5p in HIBD via regulation of Yes-associated protein 1 (YAP1)-mediated Hippo signaling pathway. The miR-192-5p, YAP1, and Hippo pathway-related factors Phospho (p)-Triaminoguanidinium azide (TAZ) in hippocampal tissues and neurons were detected. The regulatory relationship between miR-192-5p and YAP1 was verified. Neonatal hypoxic ischemia and oxygen-glucose deprivation (OGD) were used to simulate HIBD in vivo and in vitro. The neurobehavioral impairment, neuronal damage and vascular endothelial growth factor (VEGF) expression of neonatal rats in each group were detected. The viability, apoptosis and VEGF expression of hippocampal neurons in each group were also examined. MiR-192-5p expression was elevated while YAP1 expression was reduced in hippocampal tissues of HIBD rats in vivo and OGD neurons in vitro. MiR-192-5p had a targeting relation with YAP1. Suppressed miR-192-5p or overexpressed YAP1 in HIBD rats alleviated neurobehavioral impairment and neuronal damage, and decreased the expression levels of p-TAZ and VEGF expression in vivo. Reduced miR-192-5p or augmented YAP1 decelerated the neuron apoptosis, decreased the p-TAZ level and VEGF level and promoted cell viability of OGD hippocampal neurons in vitro. The study highlights that inhibited miR-192-5p protects against HIBD via regulation of YAP1 and Hippo signaling pathway, which is beneficial for HIBD treatment.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Yan</LastName>
            <ForeName>Gangli</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Puren Hospital Affiliated to Wuhan University of Science and Technology, 1 Benxi Street, Qingshan District, Wuhan, 430081, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Tao</LastName>
            <ForeName>Zhiwei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Wuhan Asia General Hospital, Wuhan, 430090, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xing</LastName>
            <ForeName>Xiaobing</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Puren Hospital Affiliated to Wuhan University of Science and Technology, 1 Benxi Street, Qingshan District, Wuhan, 430081, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Ziying</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Puren Hospital Affiliated to Wuhan University of Science and Technology, 1 Benxi Street, Qingshan District, Wuhan, 430081, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xinghua</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Puren Hospital Affiliated to Wuhan University of Science and Technology, 1 Benxi Street, Qingshan District, Wuhan, 430081, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xing</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Puren Hospital Affiliated to Wuhan University of Science and Technology, 1 Benxi Street, Qingshan District, Wuhan, 430081, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Fengguang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Puren Hospital Affiliated to Wuhan University of Science and Technology, 1 Benxi Street, Qingshan District, Wuhan, 430081, Hubei, China. Lifengguang656@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Neurochem Res</MedlineTA>
        <NlmUniqueID>7613461</NlmUniqueID>
        <ISSNLinking>0364-3190</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000627970">MIRN192 microRNA, rat</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000091102">YAP-Signaling Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C509425">Yap1 protein, rat</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000090683" MajorTopicYN="N">Hippo Signaling Pathway</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020925" MajorTopicYN="Y">Hypoxia-Ischemia, Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000091102" MajorTopicYN="N">YAP-Signaling Proteins</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Apoptosis</Keyword>
        <Keyword MajorTopicYN="N">Cell viability</Keyword>
        <Keyword MajorTopicYN="N">Hippo signaling pathway</Keyword>
        <Keyword MajorTopicYN="N">Hypoxic-ischemic brain damage</Keyword>
        <Keyword MajorTopicYN="N">Vascular endothelial growth factor</Keyword>
        <Keyword MajorTopicYN="N">Yes-associated protein 1</Keyword>
        <Keyword MajorTopicYN="N">microRNA-192-5p</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
          <Hour>12</Hour>
          <Minute>17</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35084661</ArticleId>
        <ArticleId IdType="doi">10.1007/s11064-021-03518-4</ArticleId>
        <ArticleId IdType="pii">10.1007/s11064-021-03518-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wei W et al (2019) Neuroprotective effect of verbascoside on hypoxic-ischemic brain damage in neonatal rat. Neurosci Lett 711:134415</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2019.134415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F et al (2019) Neuroprotective effects of AG490 in neonatal hypoxic-ischemic brain injury. Mol Neurobiol 56(12):8109–8123</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-019-01656-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li XL, Hong M (2020) Aqueous extract of Dendrobium officinale confers neuroprotection against hypoxic-ischemic brain damage in neonatal rats. Kaohsiung J Med Sci 36(1):43–53</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/kjm2.12139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sisa C et al (2019) Properdin: a novel target for neuroprotection in neonatal hypoxic-ischemic brain injury. Front Immunol 10:2610</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2019.02610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plaschke K et al (2008) VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol 214(2):285–292</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2008.08.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Z et al (2019) Early TLR4 inhibition reduces hippocampal injury at puberty in a rat model of neonatal hypoxic-ischemic brain damage via regulation of neuroimmunity and synaptic plasticity. Exp Neurol 321:113039</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2019.113039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou WL et al (2019) Protective effects of polygalasaponin F on oxidative stress and apoptosis-induced ischemic myocardial injury in neonatal rats with hypoxic-ischemic brain damage. NeuroReport 30(17):1148–1156</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/WNR.0000000000001330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Latorre J et al (2020) Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes. EBioMedicine 53:102697</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2020.102697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He R et al (2017) Comprehensive investigation of aberrant microRNAs expression in cells culture model of MnCl2-induced neurodegenerative disease. Biochem Biophys Res Commun 486(2):342–348</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2017.03.041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He XW et al (2019) Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis. Atherosclerosis 289:36–43</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.atherosclerosis.2019.08.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang C et al (2019) Baicalin alleviates 6-hydroxydopamine-induced neurotoxicity in PC12 cells by down-regulation of microRNA-192-5p. Brain Res 1708:84–92</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2018.12.015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X et al (2020) MiR-195-5p inhibits malignant progression of cervical cancer by targeting YAP1. Onco Targets Ther 13:931–944</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/OTT.S227826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin H et al (2018) Oroxylin A inhibits ethanol-induced hepatocyte senescence via YAP pathway. Cell Prolif 51(3):e12431</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cpr.12431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geng C, Wei J, Wu C (2018) Yap-Hippo pathway regulates cerebral hypoxia-reoxygenation injury in neuroblastoma N2a cells via inhibiting ROCK1/F-actin/mitochondrial fission pathways. Acta Neurol Belg 120:879</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13760-018-0944-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Millar G, Coggins JR (1986) The complete amino acid sequence of 3-dehydroquinate synthase of Escherichia coli K12. FEBS Lett 200(1):11–17</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-5793(86)80501-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng J et al (2020) The role and regulatory mechanism of hippo signaling components in the neuronal system. Front Immunol 11:281</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2020.00281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang P et al (2019) Exploration of MST1-mediated secondary brain injury induced by intracerebral hemorrhage in rats via hippo signaling pathway. Transl Stroke Res 10(6):729–743</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12975-019-00702-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harding B et al (2016) Glucocorticoids protect neonatal rat brain in model of hypoxic-ischemic encephalopathy (HIE). Int J Mol Sci 18(1):17</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18010017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng Z, Liu J, Ju R (2013) Hyperbaric oxygen treatment promotes neural stem cell proliferation in the subventricular zone of neonatal rats with hypoxic-ischemic brain damage. Neural Regen Res 8(13):1220–1227</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25206416</ArticleId>
            <ArticleId IdType="pmc">4107609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X et al (2004) Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol 187(1):94–104</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2004.01.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knox-Concepcion KR et al (2019) Repression of the glucocorticoid receptor increases hypoxic-ischemic brain injury in the male neonatal rat. Int J Mol Sci 20(14):3493</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20143493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jegatheesan P et al (2019) Is N-carbamoyl putrescine, the decarboxylation derivative of citrulline, a regulator of muscle protein metabolism in rats? Nutrients 11(11):2637</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu11112637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao B, Lei QY, Guan KL (2008) The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20(6):638–646</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ceb.2008.10.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lan XB et al (2019) Neuroprotective effect of Vanillin on hypoxic-ischemic brain damage in neonatal rats. Biomed Pharmacother 118:109196</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y et al (2017) miR-192–5p mediates hypoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes via targeting of FABP3. J Biochem Mol Toxicol 31(4):e21873</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbt.21873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X et al (2020) microRNA-192-5p is involved in nerve repair in rats with peripheral nerve injury by regulating XIAP. Cell Cycle 19(3):326–338</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15384101.2019.1710916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ayaz L, Dinc E (2018) Evaluation of microRNA responses in ARPE-19 cells against the oxidative stress. Cutan Ocul Toxicol 37(2):121–126</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15569527.2017.1355314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu LMN et al (2018) Programming of schwann cells by Lats1/2-TAZ/YAP signaling drives malignant peripheral nerve sheath tumorigenesis. Cancer Cell 33(2):292-308 e7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2018.01.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu T et al (2017) YAP1 up-regulation inhibits apoptosis of aortic dissection vascular smooth muscle cells. Eur Rev Med Pharmacol Sci 21(20):4632–4639</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29131252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu X et al (2019) Role of Hippo/YAP signaling in irradiation-induced glioma cell apoptosis. Cancer Manag Res 11:7577–7585</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CMAR.S210825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu CY et al (2019) Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression. Environ Toxicol 34(8):902–911</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/tox.22761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X et al (2017) YAP/TAZ orchestrate VEGF signaling during developmental angiogenesis. Dev Cell 42(5):462-478 e7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.devcel.2017.08.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan X et al (2020) YAP promotes endothelial barrier repair by repressing STAT3/VEGF signaling. Life Sci 256:117884</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lfs.2020.117884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du Y et al (2018) VEGFR2 and VEGF-C suppresses the epithelial-mesenchymal transition via YAP in retinal pigment epithelial cells. Curr Mol Med 18(5):273–286</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1566524018666181004115304</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
